290 related articles for article (PubMed ID: 8406809)
21. Effects of reproductive hormones on experimental vaginal candidiasis.
Fidel PL; Cutright J; Steele C
Infect Immun; 2000 Feb; 68(2):651-7. PubMed ID: 10639429
[TBL] [Abstract][Full Text] [Related]
22. Local expression of vaginal Th1 and Th2 cytokines in murine vaginal candidiasis under different immunity conditions.
Chen S; Li S; Wu Y; Liu Z; Li J
J Huazhong Univ Sci Technolog Med Sci; 2008 Aug; 28(4):476-9. PubMed ID: 18704316
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis.
Wozniak KL; Palmer G; Kutner R; Fidel PL
Med Mycol; 2005 Nov; 43(7):589-601. PubMed ID: 16396244
[TBL] [Abstract][Full Text] [Related]
24. Immunity to Candida.
Fidel PL
Oral Dis; 2002; 8 Suppl 2():69-75. PubMed ID: 12164664
[TBL] [Abstract][Full Text] [Related]
25. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans.
de Bernardis F; Santoni G; Boccanera M; Spreghini E; Adriani D; Morelli L; Cassone A
Infect Immun; 2000 Jun; 68(6):3297-304. PubMed ID: 10816477
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo.
Powrie F; Menon S; Coffman RL
Eur J Immunol; 1993 Nov; 23(11):3043-9. PubMed ID: 8223881
[TBL] [Abstract][Full Text] [Related]
27. Local production of chemokines during experimental vaginal candidiasis.
Saavedra M; Taylor B; Lukacs N; Fidel PL
Infect Immun; 1999 Nov; 67(11):5820-6. PubMed ID: 10531235
[TBL] [Abstract][Full Text] [Related]
28. Multiple experimental designs to evaluate the role of T-cell-mediated immunity against experimental vaginal Candida albicans infection.
Wormley FL; Cutright J; Fidel PL
Med Mycol; 2003 Oct; 41(5):401-9. PubMed ID: 14653516
[TBL] [Abstract][Full Text] [Related]
29. Vaginal Heparan Sulfate Linked to Neutrophil Dysfunction in the Acute Inflammatory Response Associated with Experimental Vulvovaginal Candidiasis.
Yano J; Noverr MC; Fidel PL
mBio; 2017 Mar; 8(2):. PubMed ID: 28292981
[TBL] [Abstract][Full Text] [Related]
30. Local Th1/Th2 cytokine expression in experimental murine vaginal candidiasis.
Ouyang W; Chen S; Liu Z; Wu Y; Li J
J Huazhong Univ Sci Technolog Med Sci; 2008 Jun; 28(3):352-5. PubMed ID: 18563341
[TBL] [Abstract][Full Text] [Related]
31. Mannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice.
Pietrella D; Mazzolla R; Lupo P; Pitzurra L; Gomez MJ; Cherniak R; Vecchiarelli A
Infect Immun; 2002 Dec; 70(12):6621-7. PubMed ID: 12438334
[TBL] [Abstract][Full Text] [Related]
32. Effects of cyclophosphamide on murine candidiasis.
Moser SA; Domer JE
Infect Immun; 1980 Feb; 27(2):376-86. PubMed ID: 6991413
[TBL] [Abstract][Full Text] [Related]
33. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
Zhang X; Li T; Chen X; Wang S; Liu Z
BMC Microbiol; 2018 Oct; 18(1):166. PubMed ID: 30359236
[TBL] [Abstract][Full Text] [Related]
34. CD86 (B7-2), but not CD80 (B7-1), expression in the epidermis of transgenic mice enhances the immunogenicity of primary cutaneous Candida albicans infections.
Gaspari AA; Burns R; Nasir A; Ramirez D; Barth RK; Haidaris CG
Infect Immun; 1998 Sep; 66(9):4440-9. PubMed ID: 9712799
[TBL] [Abstract][Full Text] [Related]
35. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.
Brieland J; Essig D; Jackson C; Frank D; Loebenberg D; Menzel F; Arnold B; DiDomenico B; Hare R
Infect Immun; 2001 Aug; 69(8):5046-55. PubMed ID: 11447185
[TBL] [Abstract][Full Text] [Related]
36. Influence of leflunomide on gastrointestinal Candida albicans infection induced in naive and arthritic newborn mice.
Dimitrova P; Ivanovska N
Int Immunopharmacol; 2006 Nov; 6(11):1682-9. PubMed ID: 16979122
[TBL] [Abstract][Full Text] [Related]
37. Knockout of autophagy gene, ATG5 in mice vaginal cells abrogates cytokine response and pathogen clearance during vaginal infection of Candida albicans.
Shroff A; Sequeira R; Patel V; Reddy KVR
Cell Immunol; 2018 Feb; 324():59-73. PubMed ID: 29306553
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo.
Powrie F; Menon S; Coffman RL
Eur J Immunol; 1993 Sep; 23(9):2223-9. PubMed ID: 8370402
[TBL] [Abstract][Full Text] [Related]
39. Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice.
Cenci E; Romani L; Vecchiarelli A; Puccetti P; Bistoni F
Infect Immun; 1989 Nov; 57(11):3581-7. PubMed ID: 2572556
[TBL] [Abstract][Full Text] [Related]
40. Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis.
Leigh JE; Steele C; Wormley FL; Luo W; Clark RA; Gallaher W; Fidel PL
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):373-80. PubMed ID: 9833746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
